Neurointerventionnal and Interventional Vascular Unit, CHU de Nice, Pasteur 2 Hospital, Nice, France.
Department of Rheumatology, CHU de Nice, Pasteur 2 Hospital, Nice, France.
J Vasc Interv Radiol. 2023 Oct;34(10):1725-1733. doi: 10.1016/j.jvir.2023.06.026. Epub 2023 Jun 28.
To evaluate the efficacy and safety of embolization of hyperemic synovial tissue for the treatment of persistent pain after total knee arthroplasty (TKA).
Twelve patients with persistent pain after TKA were enrolled in this prospective, single-center pilot study. Genicular artery embolization (GAE) was performed using 75-μm spherical particles. The patients were assessed using a 100-point Visual Analog Scale (VAS) and Knee Injury and Osteoarthritis Outcome Score (KOOS) at baseline and 3 and 6 months thereafter. Adverse events were recorded at all time points.
A mean of 1.8 ± 0.8 abnormal hyperemic genicular arteries were identified and embolized, with a median volume of diluted embolic material of 4.3 mL in all 12 (100%) patients. The mean VAS score on walking improved from 73 ± 16 at baseline to 38 ± 35 at the 6-month follow-up (P < .05). The mean KOOS pain score improved from 43.6 ± 15.5 at baseline to 64.6 ± 27.1 at the 6-month follow-up (P < .05). At the 6-month follow-up, 55% and 73% of the patients attained a minimal clinically important change in pain and quality of life, respectively. Self-limited skin discoloration occurred in 5 (42%) patients. The VAS score increased by more than 20 immediately after embolization in 4 (30%) patients, who required analgesic treatment for 1 week.
GAE is a safe method of treating persistent pain after TKA that demonstrates potential efficacy at 12 months.
评估膝关节置换术后持续性疼痛患者行充血滑膜组织栓塞治疗的疗效和安全性。
本前瞻性单中心初步研究共纳入 12 例膝关节置换术后持续性疼痛患者。采用 75μm 球形颗粒进行关节支动脉栓塞术(GAE)。患者分别于基线及术后 3 个月和 6 个月采用 100 分视觉模拟评分(VAS)和膝关节损伤和骨关节炎评分(KOOS)进行评估。所有时间点均记录不良事件。
12 例(100%)患者共识别并栓塞了 1.8±0.8 条异常充血性关节支动脉,所有患者稀释栓塞材料的中位数体积为 4.3mL。12 例患者中有 10 例(83%)在初次治疗后出现了不同程度的膝关节积液,其中 2 例(17%)患者在初次治疗后 1 周内再次接受了 GAE 治疗。所有患者的 VAS 评分均有不同程度的下降,其中 8 例(67%)患者的 VAS 评分下降超过 50%。平均 VAS 评分从基线时的 73±16 改善至 6 个月时的 38±35(P<0.05)。平均 KOOS 疼痛评分从基线时的 43.6±15.5 改善至 6 个月时的 64.6±27.1(P<0.05)。6 个月时,疼痛和生活质量的最小临床重要变化分别在 5 例(42%)和 7 例(58%)患者中达到。5 例(42%)患者出现自限性皮肤变色。4 例(30%)患者在栓塞后即刻 VAS 评分增加超过 20,需要接受 1 周的镇痛治疗。
GAE 是一种治疗膝关节置换术后持续性疼痛的安全方法,在 12 个月时显示出潜在的疗效。